Aurora Cannabis Appoints International Consumer Packaged Goods Executive Miguel Martin as Chief Commercial Officer

Published: July 7, 2020

Aurora Cannabis Appoints International Consumer Packaged Goods Executive Miguel Martin as Chief Commercial Officer

Aurora Cannabis Inc., the Canadian company defining the future of cannabinoids worldwide, announced that Miguel Martin, President of Aurora USA and head of Reliva, LLC, has been appointed Chief Commercial Officer of Aurora, effective immediately. Mr. Martin will replace Darren Karasiuk who has held this position at Aurora since February 2019.

“This appointment allows us to take full advantage of Miguel’s depth of international CPG experience to drive Aurora’s revenues and brand strength in our global core markets,” said Michael Singer, Executive Chairman and Interim CEO of Aurora. “Miguel has a proven track record of running profitable global sales and marketing teams in complex, highly regulated industries that are adjacent to cannabis. His new role at Aurora is indicative of our commitment to combining sales and marketing excellence with driving profitability in our core businesses.”

Mr. Singer continued, “On behalf of our Board of Directors and management team, I would like to thank Darren for his invaluable contributions to the development of Aurora’s commercial strategy.” Mr. Karasiuk added, “I am proud of my accomplishments at Aurora, most notably leading an incredibly dedicated and talented team that has been able to achieve leading market share in Canada and abroad.”

Mr. Martin is a 25-year consumer packaged goods industry veteran having joined Aurora from Reliva where he served as Chief Executive Officer. He became President of Aurora USA upon closing of the Company’s acquisition of Reliva in May 2020. Prior to Reliva, Mr. Martin was the President of Logic Technology, one of the largest manufacturers of electronic cigarettes. He also held the positon of Senior Vice President and General Manager of Altria Sales & Distribution. Mr. Martin has deep experience operating in highly regulated industries which will be very additive to Aurora’s portfolio of high quality, rigorously tested and compliant cannabinoid product formats.

Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. For more information, please visit our website at www.auroramj.com.